![](/img/cover-not-exists.png)
Topical doxycycline foam 4% for prophylactic management of epidermal growth factor receptor inhibitor skin toxicity: an exploratory phase 2, randomized, double-blind clinical study
Shacham Shmueli, Einat, Geva, Ravit, Yarom, Nirit, Hubert, Ayala, Keynan, Rita, Kedem, Tal H., Eini, Meir, Tamarkin, Dov, Shirvan, MitchellLanguage:
english
Journal:
Supportive Care in Cancer
DOI:
10.1007/s00520-018-4600-8
Date:
January, 2019
File:
PDF, 681 KB
english, 2019